Cytora Stem

📍 Yokneam, Israel🗓 Founded 2018👥 16 employees💰 Last funded Sep 2024
Pharmaceutical Manufacturing🌐 cytorastem.com
Website LinkedIn
CYTORA is a clinical stage stem cell company developing a new class of medicines based on a novel and transformative patented platform stem cell technology derived from unique human Oral Mucosa Stem Cells (hOMSC) CYTORA has developed a revolutionary patent protected technology platform to produce “off the shelf” (allogeneic) therapeutic doses of hOMSC to treat some of the most challenging diseases of this decade including chronic wounds such as incurable diabetic foot ulcers (IDFU) and degenerative diseases such as Parkinsons Disease, Multiple System Atrophy (MSA), and Alzheimer’s Disease. Our pioneering and deeply scientific team are leading the way in stem cell therapy have years of research, patents and industry experience in the fields of biotechnology and stem cell therapy. Our vision is to improve and save the lives of millions of patients worldwide through our unique patented stem cell platform technology, making it accessible and affordable.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Cytora Stem?
Cytora Stem has 1 investors on record on gritt.io and 1 late-stage investors.
When did Cytora Stem last raise funding?
The most recent investment in Cytora Stem recorded on gritt.io was in September 2024.
When was Cytora Stem founded?
Cytora Stem was founded in 2018.
What industry is Cytora Stem in?
Cytora Stem operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Cytora Stem based?
Cytora Stem is headquartered in Yokneam, Israel.